Highlights from the CLL CTP discussion from Amsterdam 2015.
Prof Wendtner, (University of Cologne, Cologne, Germany), Dr Bosch, (Hospital Vall d'Hebron, Barcelona, Spain), Prof Ghia, (Università Vita-Salute San Raffaele, Milan, Italy) and Prof Cymbalista, (Hôpital Avicenne, Paris, France) talk to ecancertv about the evolution of chronic lymphocytic leukaemia (CLL) treatment algorithms and the effects and side effects of new targeted drugs on patients.
Dr Montillo, (Niguarda Ca’ Granda Hospital, Milan, Italy) and Dr Gomes da Silva, (Instituto Português de Oncologia de Lisboa, Lisbon, Portugal) talk to ecancertv about current haematology practices and how to decide the treatment of chronic lymphocytic leukaemia (CLL) in 2015. They discuss how the fitness scales in publications define certain treatments for cancer patients and how new treatments are changing patient assessments.